Perfusion Systems Market to Reach US$ 1,442.28 Million at CAGR of 3.8% by 2027 | The Insight Partners

Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type (Microfluidic Perfusion Systems, Small-Mammal Organ Perfusion Systems, Bioreactor Perfusion Systems, gravity or Pressure-Driven Perfusion Systems); Component (Perfusion Pumps, Oxygenators, Herat-Lung Machines, Monitoring Systems, Cannulas and Others) and Geography

Publication Month: Mar 2019 | Report Code: TIPMD00002293 | No. of Pages: 167 | Category: Medical Device | Status: Published

The global perfusion systems market accounted to US$ 1,044.75 Mn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period 2019 - 2027, to account to US$ 1,442.28 Mn by 2027.

 

The Asia Pacific perfusion systems market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on perfusion systems. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.    

 

Exhibit: Lucrative Regional Markets


 

Market Insights

Rising Need for The Organ Transplantation is expected to boost the market growth over the years

Organ transplantation is a surgical process done when a patient’s organ has stopped functioning completely. The organ transplant is commonly done for the organs such as heart, liver and kidney. However, the rising cases of the chronic diseases are leading to the need of the transplantation for the other organs such as lung, pancreases, cornea, and vascular tissues among others. The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplant and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public-private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of the organ transplantation.

 

As per the National Chronic Kidney Disease fact sheet 2017, states that approximately, 30 million people in US are estimated to have chronic kidney diseases. Similarly, according to the National Institute id Diabetes and Digestive and Kidney Diseases states that nearly 661,000 Americans have kidney failure among these nearly, 468,000 patients are taking dialysis, and approximately 193,000 have undergone kidney transplantation. Therefore, the increasing incidences are likely to grow more needs for the kidney transplantation in the coming years. Likewise, it is estimated that the growing numbers of the heart diseases are also responsible to drive the market in coming futures.

 

Rising Cell Based Research Activities

The rise in the chronic diseases, advantages of the applications of biotechnology are growing the extensive cell based research activities. The cell based assays assists in understanding the challenges of biology of the living organisms. The cell based assays helps in the understanding the aspects such as cell signaling, proliferation, apoptosis, cellular genetics, neurology, cancer and more.  The cell based assays are extensively carried out in pharmaceutical, biotechnology industries, research institutes and academics research institutes. The pharmaceutical and biopharmaceutical industries need to efficiently commercialize the drug. Therefore, cell based assays in the pharmaceutical and biotechnology industry are the driving factor for the growth of the perfusion systems.

 

The cell based assays are also extensively carried out by the contract research organization for the clinical trial studies and other processes. The chronic diseases such as cancer and other genetic related studies are enforcing for the cell based studies. For instance, Charles River offers services for the human primary cell based assays and according to an article published by the company states that the development in the cell based assays are likely to continue growing in the future.

 

Type Insights

The perfusion systems market by type is segmented into bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure driven perfusion systems, and small mammal organ perfusion systems.  In 2018, the bioreactor perfusion systems segment held a largest market share of 44.3% of the perfusion systems market, by type. This segment is also expected to dominate the market in 2027 owing to increasing production by the biopharmaceutical and pharmaceutical and its advantages including, high quality of product, product stability, and scalability. Moreover, the microfluidic perfusion systems segment is anticipated to witness the significant growth rate of 3.9% during the forecast period, 2019 to 2027 owing to increasing application of basic cell biology, molecular biological assays, tissue engineering, and systems biology.

 

Component Insights

The global perfusion systems market on the basis of component was segmented into oxygenators, heart-lung machine, perfusion pumps, monitoring systems, cannulas, and others. In 2018, the oxygenators segment held a largest market share of 33.1% of the perfusion systems market, by component. This segment is also expected to dominate the market in 2027 owing to the increasing number of the cardiovascular surgeries, liver transplantation and kidney transplantation worldwide. Moreover, the heart-lung machine segment is anticipated to witness the significant growth rate of 3.3% during the forecast period, 2019 to 2027 owing to the incidences of the coronary heart diseases.

 

Exhibit: Perfusion Systems Market, by Component


  

 

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in global perfusion systems industry. Few of the recent product launch, product approval and acquisitions are listed below:

 

2018: XVIVO Perfusion has submitted the Premarket Approval (PMA) application for the XPS with STEEN Solution to the FDA.

 

2019: Sartorius Stedim Biotech (Sartorius AG) launched ambr 250 high throughput (ht) perfusion, specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies.

 

2018: Spectrum Medical announced acquisition of the second exclusive licensing agreement with the University of California, Los Angeles (UCLA) Technology Development Group on behalf of UC Regents. The license is in association of the intellectual property that supports clinical applications requiring Extracorporeal Circulation.

 

PERFUSION SYSTEMS - MARKET SEGMENTATION

 

By Type

  • Microfluidic Perfusion Systems
  • Small-Mammal Organ Perfusion Systems
  • Bioreactor Perfusion Systems
  • Gravity or Pressure-Driven Perfusion Systems

By Component

  • Perfusion Pumps
  • Oxygenators
  • Heart-Lung Machines
  • Monitoring Systems
  • Cannulas
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

Company Profiles

  • REPLIGEN CORPORATION
  • Merck KGaA
  • Ala Scientific Instruments, Inc.
  • XVIVO Perfusion
  • Medtronic
  • XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
  • TERUMO CORPORATION
  • Getinge AB
  • Harvard Bioscience
  • OrganOx
  • Sartorius AG
  • RAND
  • LivaNova PLC
  • Sanisure (Sani-Tech West, Inc.)
  • AutoMate Scientific, Inc.
  • APD (Advanced Perfusion Diagnostics)
  • Spectrum Medical
  • Transonic Systems Inc
  • Transonic Systems Inc
  • CESCO BIOENGINEERING CO., LTD.
  • Jobst Technologies GmbH

1.          INTRODUCTION

1.1      Scope of the Study

1.2      The Insight Partners Research Report Guidance

1.3      market segmentation

1.3.1      Global Perfusion Systems Market – By Type

1.3.2      Global Perfusion Systems Market – By Component

1.3.3      Global Perfusion Systems Market – By Geography

2.          Global Perfusion systems market –  Key takeaways

3.          research Methodology

3.1.1      Coverage

3.1.2      Secondary Research

3.1.3      Primary Research

4.          Global Perfusion systems market –  market landscape

4.1      overview

4.2      pest analysis

4.2.1      North America – PEST Analysis

4.2.2      Europe– PEST Analysis

4.2.3      Asia Pacific– PEST Analysis

4.2.4      Middle East & South Africa– PEST Analysis

4.2.5      South and Central America – PEST Analysis

5.          Global perfusion systems market – Key Market Dynamics

5.1      Key Market Drivers

5.1.1      Rising Prevalence of Cardiovascular Diseases

5.1.2      Significant Growth of Pharmaceutical and Biotechnology Industries

5.1.3      Rising Need for The Organ Transplantation

5.1.4      Rising Cell Based Research Activities

5.2      Key Market Challenges

5.2.1      Expensive Organ Transplant Surgeries

5.2.2      Limited Numbers of Donors for Organ Transplant Surgeries

5.3      Key Market Opportunities

5.3.1      Growth Opportunities in Emerging Regions

5.4      Impact analysis

6.          Perfusion Systems market – Global Analysis

6.1      global Perfusion Systems market Revenue Forecasts and Analysis

6.2      global Perfusion systems market, By Geography - Forecasts and Analysis

6.3      PERFORMANCE OF KEY PLAYERS

6.3.1      Getinge AB

6.3.2      Medtronic

6.4      expert opinions

7.          Global Perfusion Systems Market analysis–  by type

7.1      overview

7.2      Global Perfusion Systems Market BY Type, 2018 & 2027 (%)

7.3      Microfluidic perfusion systems Market

7.3.1      Overview

7.3.2      Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

7.4      Small-Mammal Organ perfusion systems market

7.4.1      Overview

7.4.2      Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

7.5      bioreactors perfusion systems maRKET

7.5.1      Overview

7.5.2      Global Bioreactors Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

7.6      gravity or pressure-driven perfusion systems maRKET

7.6.1      Overview

7.6.2      Global Gravity or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.           global perfusion systems Market analysis–  by component

8.1      overview

8.2      Global perfusion systems Market, BY component 2018 & 2027 (%)

8.3      perfusion pumps market

8.3.1      Overview

8.3.2      Global Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

8.4      Oxygenators market

8.4.1      Overview

8.4.2      Global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)

8.5      heart lung Machine market

8.5.1      Overview

8.5.2      Global Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)

8.6      Monitoring Systems market

8.6.1      Overview

8.6.2      Global Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.7      Cannulas market

8.7.1      Overview

8.7.2      Global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)

8.8      Others market

8.8.1      Overview

8.8.2      Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Perfusion SYstems MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS

9.1      north america Perfusion Systems market

9.1.1      Overview

9.1.2      North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3      North America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.4      North America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.1.5      North America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.1.6      US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7      US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    US Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2    US Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.1.8      Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9      Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.1    Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.2    Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.1.10    Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.11    Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.1.11.1 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.1.11.2 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2      Europe Perfusion SYstems market

9.2.1      Overview

9.2.2      Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.3      Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.4      Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.5      Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.2.6      Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7      Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1    Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.7.2    Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.8      UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9      UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1    UK Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.9.2    UK Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.10    France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.11    France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.2.11.1 France Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.2.11.2 France Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.12    Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.13    Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.2.13.1 Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.2.13.2 Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.14    Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.15    Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.2.15.1 Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.2.15.2 Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3      ASIA Pacific perfusion systems MARKET

9.3.1      Overview

9.3.2      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.4      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.5      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.3.6      China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7      China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1    China Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.7.2    China Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.8      Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9      Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1    Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.9.2    Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.10    India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.11    India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.3.11.1 India Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.3.11.2 India Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.12    Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.13    Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.3.13.1 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.3.13.2 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.14    South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.15    South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.3.15.1 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.3.15.2 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.4      Middle East & Africa Perfusion Systems market

9.4.1      Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.2      Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.3      Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Component  (US$ Mn)

9.4.4      Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.4.5      UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6      UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1    UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.6.2    UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.4.7      Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8      Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1    Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.8.2    Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.4.9      South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.10    South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                        9.4.10.1. South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                        9.4.10.2. South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.5      SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET

9.5.1      Overview

9.5.2      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.4      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.5.5      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.5.6      Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7      Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1    Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.7.2    Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.5.8      Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.9      Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.9.1    Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.9.2    Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

10.        PERFUSION SYSTEMS MARKET –Industry Landscape

10.1    Overview

10.2    Growth Strategies in the perfusion systems Market, 2015-2018

10.3    Organic Developments

10.3.1    Overview

10.4    Organic Growth Strategies in the perfusion systems Market, 2016-2018

10.5    Product Approval

10.5.1    Recent Product Approval by Players in the Perfusion Systems Market, 2015-2018

10.6    Product Launch

10.6.1    Recent Product Launch by Players in the Perfusion Systems Market, 2015-2018

10.7    Others

10.7.1    Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018

10.8    Inorganic developments

10.8.1    Overview

10.9    inOrganic Growth Strategies in the perfusion systems Market,
2015-2018

10.10  Acquisition

10.10.1  Acquisition Made by the Players in the perfusion systems Market, 2015-2018

10.11  Partnerships

10.11.1  Recent Partnership by Players in the Perfusion Systems Market, 2015-2018

10.12  Collaboration

10.12.1  Collaboration by Players in the Perfusion Systems Market, 2015-2018

10.13  Agreement

10.13.1  Agreement Made by the Players in the Perfusion Systems Market, 2015-2018

11.        Perfusion Systems Market–Key company profiles

11.1    Existing Players

11.1.1    REPLIGEN CORPORATION

11.1.1.1  Key Facts

11.1.1.2  Business Description

11.1.1.3  Financial Overview

11.1.1.4  Product Portfolio

11.1.1.5  SWOT Analysis

11.1.1.6  Key Developments

11.1.2    Merck KGaA

11.1.2.1  Key Facts

11.1.2.2  Business Description

11.1.2.3  Financial Overview

11.1.2.4  Product Portfolio

11.1.2.5  SWOT Analysis

11.1.2.6  Key Developments

11.1.3    ALA Scientific Instruments, Inc.

11.1.3.1  Key Facts

11.1.3.2  Business Description

11.1.3.3  Financial Overview

11.1.3.4  Product Portfolio

11.1.3.5  SWOT Analysis

11.1.3.6  Key Developments

11.1.4    XVIVO Perfusion

11.1.4.1  Key Facts

11.1.4.2  Business Description

11.1.4.3  Financial Information

11.1.4.4  Product Portfolio

11.1.4.5  SWOT Analysis

11.1.4.6  Key Developments


11.1.5    Medtronic

11.1.5.1  Key Facts

11.1.5.2  Business Description

11.1.5.3  Financial Information

11.1.5.4  Product Portfolio

11.1.5.5  SWOT Analysis

11.1.5.6  Key Developments

11.1.6    XENIOS AG (Fresenius Medical Care AG & Co. KGaA)

11.1.6.1  Key Facts

11.1.6.2  Business Description

11.1.6.3  Financial Information

11.1.6.4  Product Portfolio

11.1.6.5  SWOT Analysis

11.1.6.6  Key Developments

11.1.7    TERUMO CORPORATION

11.1.7.1  Key Facts

11.1.7.2  Business Description

11.1.7.3  Financial Overview

11.1.7.4  Product Portfolio

11.1.7.5  SWOT Analysis

11.1.7.6  Key Developments

11.1.8    Getinge AB

11.1.8.1  Key Facts

11.1.8.2  Business Description

11.1.8.3  Financial Overview

11.1.8.4  Product Portfolio

11.1.8.5  SWOT Analysis

11.1.8.6  Key Developments

11.1.9    Harvard Bioscience

11.1.9.1  Key Facts

11.1.9.2  Business Description

11.1.9.3  Financial Overview

11.1.9.4  Product Portfolio

11.1.9.5  SWOT Analysis

11.1.9.6  Key Developments

11.1.10  OrganOx

                       11.1.10.1 Key Facts

                       11.1.10.2 Business Description

                       11.1.10.3 Financial Overview

                       11.1.10.4 Product Portfolio

                       11.1.10.5 SWOT Analysis

                       11.1.10.6 Key Developments

11.2    Emerging Players

11.2.1    Sartorius AG

11.2.1.1  Key Facts

11.2.1.2  Business Description

11.2.1.3  Financial Overview

11.2.1.4  Product Portfolio

11.2.1.5  SWOT Analysis

11.2.1.6  Key Developments

11.2.2    RAND

11.2.2.1  Key Facts

11.2.2.2  Business Description

11.2.2.3  Financial Overview

11.2.2.4  Product Portfolio

11.2.2.5  SWOT Analysis

11.2.2.6  Key Developments

11.2.3    LivaNova PLC

11.2.3.1  Key Facts

11.2.3.2  Business Description

11.2.3.3  Financial Overview

11.2.3.4  Product Portfolio

11.2.3.5  SWOT Analysis

11.2.3.6  Key Developments

11.2.4    Sanisure (Sani-Tech West, Inc.)

11.2.4.1  Key Facts

11.2.4.2  Business Description

11.2.4.3  Financial Overview

11.2.4.4  Product Portfolio

11.2.4.5  SWOT Analysis

11.2.4.6  Key Developments

11.2.5    AutoMate Scientific, Inc.

11.2.5.1  Key Facts

11.2.5.2  Business Description

11.2.5.3  Financial Overview

11.2.5.4  Product Portfolio

11.2.5.5  SWOT Analysis

11.2.5.6  Key Developments

11.2.6    APD (Advanced Perfusion Diagnostics)

11.2.6.1  Key Facts

11.2.6.2  Business Description

11.2.6.3  Financial Overview

11.2.6.4  Product Portfolio

11.2.6.5  SWOT Analysis

11.2.6.6  Key Developments

11.2.7    Spectrum Medical

11.2.7.1  Key Facts

11.2.7.2  Business Description

11.2.7.3  Financial Overview

11.2.7.4  Product Portfolio

11.2.7.5  SWOT Analysis

11.2.7.6  Key Developments

11.2.8    Transonic Systems Inc.

11.2.8.1  Key Facts

11.2.8.2  Business Description

11.2.8.3  Financial Overview

11.2.8.4  Product Portfolio

11.2.8.5  SWOT Analysis

11.2.8.6  Key Developments

11.2.9    ISCHEMAVIEW, INC

11.2.9.1  Key Facts

11.2.9.2  Business Description

11.2.9.3  Financial Overview

11.2.9.4  Product Portfolio

11.2.9.5  SWOT Analysis

11.2.9.6  Key Developments

11.2.10  CESCO BIOENGINEERING CO., LTD.

                       11.2.10.1 Key Facts

                       11.2.10.2 Business Description

                       11.2.10.3 Financial Overview

                       11.2.10.4 Product Portfolio

                       11.2.10.5 SWOT Analysis

                       11.2.10.6 Key Developments

11.2.11  Jobst Technologies GmbH

                       11.2.11.1 Key Facts

                       11.2.11.2 Business Description

                       11.2.11.3 Financial Overview

                       11.2.11.4 Product Portfolio

                       11.2.11.5 SWOT Analysis

                       11.2.11.6 Key Developments

12.        Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms

 

LIST OF TABLES

TABLE 1.           North America Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 2.           North America perfusion systems Market Revenue And Forecasts to 2027, By component  (US$ Mn)

TABLE 3.           US Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 4.           US perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 5.           Canada Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 6.           Canada perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 7.           Mexico Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 8.           Mexico perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 9.           Europe Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 10.         Europe perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)

TABLE 11.         Germany Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 12.         Germany perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 13.         UK Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 14.         UK perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 15.         France Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 16.         France perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 17.         Spain Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 18.         Spain perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 19.         Italy Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 20.         Italy perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 21.         Asia Pacific Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 22.         Asia Pacific perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)

TABLE 23.         China Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 24.         China perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 25.         Japan Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 26.         Japan perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 27.         India Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 28.         India perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 29.         Australia Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 30.         Australia perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 31.         South Korea Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 32.         South Korea perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 33.         Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 34.         Middle East & Africa perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)

TABLE 35.         UAE Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 36.         UAE perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 37.         Saudi Arabia Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 38.         Saudi Arabia perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 39.         South Africa Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 40.         South Africa perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 41.         South and Central America Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 42.         South and Central America perfusion systems Market Revenue And Forecasts to 2027,  By component (US$ Mn)

TABLE 43.         Brazil Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 44.         Brazil perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 45.         Argentina Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 46.         Argentina perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 47.         Recent Product approval By Players in the perfusion systems Market, 2015-2018

TABLE 48.         Recent Product Launch By Players in the perfusion systems Market, 2015-2018

TABLE 49.         Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018

TABLE 50.         Acquisition made by the players in the perfusion systems market, 2015-2018

TABLE 51.         Recent Partnership in the perfusion systems Market, 2015-2018

TABLE 52.         Collaboration in the perfusion systems Market, 2015-2018

TABLE 53.         Agreement made by the players in the Perfusion Systems market, 2015-2018

TABLE 54.         Glossary of Terms, Perfusion systems market

LIST OF FIGURES

FIGURE 1.         Perfusion Systems market Segmentation

FIGURE 2.         perfusion systems Segmentation, by region

FIGURE 3.         Asia Pacific Perfusion systems market, Revenue (US$ Mn), By Geography 2018 & 2027

FIGURE 4.         Global Perfusion systems market By Type, Market Share (%), 2018

FIGURE 5.         Global Perfusion systems market By Component, Market Share (%), 2018

FIGURE 6.         North America PEST Analysis

FIGURE 7.         Europe PEST Analysis

FIGURE 8.         Asia pacific PEST Analysis

FIGURE 9.         Middle East & South Africa PEST Analysis

FIGURE 10.       South and central america PEST Analysis

FIGURE 11.       perfusion systems market impact analysis of driver and Challenges

FIGURE 12.       global Perfusion Systems market – Revenue Forecasts and Analysis –2018- 2027

FIGURE 13.       global Perfusion systems market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 14.       Global Perfusion systems Market, by Type 2018 & 2027 (%)

FIGURE 15.       Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 16.       Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027  (US$ Mn)

FIGURE 17.       Global Bioreactors perfusion systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.       Global Gravity Or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.       global perfusion systems Market, by component 2018 & 2027 (%)

FIGURE 20.       global perfusion pumps Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.       global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.       global heart-lung machine Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23.       global monitoring systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.       global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.       global others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26.       North America Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 27.       North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 28.       North America perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 29.       US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.       Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 31.       Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.       Europe Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 33.       Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34.       Europe perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 35.       Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36.       UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37.       France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38.       Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39.       Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40.       Asia Pacific Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 41.       Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 42.       Asia Pacific perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 43.       China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44.       Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45.       India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.       Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47.       South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 48.       Middle East & Africa Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 49.       Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 50.       Middle East & Africa perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 51.       UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.       Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 53.       South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 54.       South and Central America Perfusion SYstems Market revenue Overview, by Country (2017)  (us $ mn)

FIGURE 55.       South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 56.       South and Central America perfusion systems Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 57.       Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58.       Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 59.       Growth Strategies in the perfusion systems Market, 2015-2018

FIGURE 60.       Organic Growth Strategies in the perfusion systems Market, 2016-2018

FIGURE 61.       Inorganic developments in the perfusion systems Market, 2015-2018

The List of Companies

Existing Players

  1. REPLIGEN CORPORATION
  2. Merck KGaA
  3. Ala Scientific Instruments, Inc.
  4. XVIVO Perfusion
  5. Medtronic
  6. XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
  7. TERUMO CORPORATION
  8. Getinge AB
  9. Harvard Bioscience
  10. OrganOx

Emerging Players

  1. Sartorius AG
  2. RAND
  3. LivaNova PLC
  4. Sanisure (Sani-Tech West, Inc.)
  5. AutoMate Scientific, Inc.
  6. APD (Advanced Perfusion Diagnostics)
  7. Spectrum Medical
  8. Transonic Systems Inc
  9. Transonic Systems Inc
  10. CESCO BIOENGINEERING CO., LTD.
  11. Jobst Technologies GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the perfusion systems market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global perfusion systems treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550